Cytophage Technologies (TSXV:CYTO) Net Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Cytophage Technologies Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Cytophage Technologies's Net Income for the three months ended in Mar. 2024 was C$-4.28 Mil. Cytophage Technologies's Revenue for the three months ended in Mar. 2024 was C$0.00 Mil. Therefore, Cytophage Technologies's net margin for the quarter that ended in Mar. 2024 was 0.00%.

The historical rank and industry rank for Cytophage Technologies's Net Margin % or its related term are showing as below:

TSXV:CYTO's Net Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -148.41
* Ranked among companies with meaningful Net Margin % only.

Cytophage Technologies Net Margin % Historical Data

The historical data trend for Cytophage Technologies's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytophage Technologies Net Margin % Chart

Cytophage Technologies Annual Data

Trend

Dec21

Dec22

Dec23

Net Margin %

Cytophage Technologies Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Net Margin %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Cytophage Technologies's Net Margin %

For the Biotechnology subindustry, Cytophage Technologies's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cytophage Technologies's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cytophage Technologies's Net Margin % distribution charts can be found below:

* The bar in red indicates where Cytophage Technologies's Net Margin % falls into.

Cytophage Technologies Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Cytophage Technologies's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	0.022	/	0
	=	%

Cytophage Technologies's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin	=	Net Income (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-4.284	/	0
	=	%

Cytophage Technologies (TSXV:CYTO) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Cytophage Technologies Net Margin % Related Terms

Thank you for viewing the detailed overview of Cytophage Technologies's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytophage Technologies (TSXV:CYTO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a 'phage-display' methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health.